Mink Therapeutics Inc
NASDAQ:INKT

Watchlist Manager
Mink Therapeutics Inc Logo
Mink Therapeutics Inc
NASDAQ:INKT
Watchlist
Price: 12.04 USD 3.26% Market Closed
Market Cap: 56.5m USD

Wall Street
Price Targets

INKT Price Targets Summary
Mink Therapeutics Inc

Wall Street analysts forecast INKT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.

Lowest
Price Target
35.35 USD
194% Upside
Average
Price Target
39.78 USD
230% Upside
Highest
Price Target
45.15 USD
275% Upside
Mink Therapeutics Inc Competitors:
Price Targets
RXRX
Recursion Pharmaceuticals Inc
64% Upside
DTIL
Precision BioSciences Inc
667% Upside
CRVO
Diffusion Pharmaceuticals Inc
172% Upside
EXAS
Exact Sciences Corp
1% Downside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
61% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
33% Upside
KMDA
Kamada Ltd
88% Upside
MRUS
Merus NV
3% Upside

Revenue
Forecast

Revenue Estimate
Mink Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Mink Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Mink Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INKT's stock price target?
Price Target
39.78 USD

According to Wall Street analysts, the average 1-year price target for INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.

Back to Top